ClinicalTrials.gg
CompletedNCT04325282TMS4BECTSUpdated Sep 4, 2025Results posted

Transcranial Magnetic Stimulation for BECTS

An interventional study of Active rTMS and Sham rTMS in Benign Epilepsy With Centrotemporal Spikes, Language Problems and Learning Disorders, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-09-04.

Sponsored by Stanford University · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Not applicable
Ages
5 Years to 18 Years
Sex
All
01

Study summary

Benign epilepsy with centrotemporal spikes (BECTS) is the most common pediatric epilepsy syndrome. Affected children typically have a mild seizure disorder, but yet have moderate difficulties with language, learning and attention that impact quality of life more than the seizures. Separate from the seizures, these children have very frequent abnormal activity in their brain known as interictal epileptiform discharges (IEDs, or spikes), which physicians currently do not treat. These IEDs arise near the motor cortex, a region in the brain that controls movement.

In this study, the investigators will use a form of non-invasive brain stimulation called transcranial magnetic stimulation (TMS) to determine the impact of IEDs on brain regions important for language to investigate: (1) if treatment of IEDs could improve language; and (2) if brain stimulation may be a treatment option for children with epilepsy.

Participating children will wear electroencephalogram (EEG) caps to measure brain activity. The investigators will use TMS to stimulate the brain region where the IEDs originate to measure how this region is connected to other brain regions. Children will then receive a special form of TMS called repetitive TMS (rTMS) that briefly reduces brain excitability. The study will measure if IEDs decrease and if brain connectivity changes after rTMS is applied.

The investigators hypothesize that the IEDs cause language problems by increasing connectivity between the motor cortex and language regions. The investigators further hypothesize that rTMS will reduce the frequency of IEDs and also reduce connectivity between the motor and language region

02

Conditions studied

  • Benign Epilepsy With Centrotemporal Spikes
  • Language Problems
  • Learning Disorders

Keywords

  • Transcranial Magnetic Stimulation (TMS)
  • Electroencephalogram (EEG)
  • Children
  • Pediatric
  • Interictal Epileptiform Discharges
  • Brain connectivity
03

In context

Epilepsy, Rolandic

23 studies on the registry are indexed under Epilepsy, Rolandic; 3 are open to participants now.

This study's enrollment of 22 is below the median of 44 across 13 interventional studies indexed under Epilepsy, Rolandic.

Browse Epilepsy, Rolandic studies →

Lead sponsor

Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.

Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A diagnosis of Benign Epilepsy with Centrotemporal Spikes (BECTS), sometimes called Rolandic Epilepsy. Diagnosis will be based on a history of a focal motor seizure (affecting the face or causing hypersalivation) or a history of a seizure out of sleep AND an EEG with unilateral or bilateral centrotemporal spike waves.
  • English-speaking

Exclusion criteria

Exclusion Criteria:

  • History of prematurity \< 35 weeks gestational age;
  • History of serious neurologic problems (i.e. history of other seizure disorder other than simple febrile seizure, head trauma with prolonged loss of consciousness, cerebrovascular accident or neuro-inflammatory disease)
  • Focal deficits on neurologic exam
  • History of abnormal MRI (with clear gray or white matter abnormality)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Children with BECTS

    Children will receive sham and active rTMS on 2 separate study visits separated by at least 1 week.

    Device: Active rTMS · Device: Sham rTMS

Interventions

  • DeviceActive rTMS

    1Hz rTMS delivered for 15-20 minutes

  • DeviceSham rTMS

    sham rTMS delivered for 15-20 minutes

06

What researchers measure

Primary outcomes

  1. Interictal Epileptiform Discharge (IED) Frequency

    We will count the number of IEDs/minute before and after application of active rTMS as well as before and after sham rTMS. We will compare the change in IEDs induced by the active and sham stimulation.

    Time frame: Before and after intervention (approximately 4 hours/visit on 2 study days one week apart)

Secondary outcomes

  1. Change in Brain Connectivity

    We will measure brain connectivity before and after application of active rTMS as well as before and after sham rTMS. We will compare the change in connectivity induced by the active and sham stimulation. In particular, we will look at how connectivity changes between the motor cortex and language regions of the brain. We chose 3 regions of interest per hemisphere (-F: Frontal, -M: Motor, -T: Temporal). rTMS was applied to the hemisphere with more spikes on clinical EEG, and hence all regions were further qualified as being ipsilateral (i-) or contralateral (c-) to rTMS application. Connectivity is measured in the weighted Phase Lag Index (wPLI) in the beta-frequency band, a phase-based connectivity measure which runs from a theoretical minimum of 0 (no connectivity) to 1 (complete connectivity).

    Time frame: Before and after intervention (approximately 4 hours/visit on 2 study days one week apart)

07

Results

Posted Sep 4, 2025

Participant flow

This study enrolled participants with Self Limited Epilepsy with Centrotemporal Spikes (SeLECTS), formerly known as Benign Epilepsy with Centrotemporal Spikes (BECTS).

First Intervention (1 Day)
Participant flow — First Intervention (1 Day)
MilestoneChildren With SeLECTS - Active, Then Sham rTMSChildren With SeLECTS - Sham, Then Active rTMS
Started1111
Completed1110
Not completed01
Withdrew: Withdrawal by subject01
Washout Period (1 Week)
Participant flow — Washout Period (1 Week)
MilestoneChildren With SeLECTS - Active, Then Sham rTMSChildren With SeLECTS - Sham, Then Active rTMS
Started1110
Completed1110
Not completed00
Second Intervention (1 Day)
Participant flow — Second Intervention (1 Day)
MilestoneChildren With SeLECTS - Active, Then Sham rTMSChildren With SeLECTS - Sham, Then Active rTMS
Started1110
Completed119
Not completed01
Withdrew: Withdrawal by subject01

Outcome measures

PrimaryInterictal Epileptiform Discharge (IED) Frequency

We will count the number of IEDs/minute before and after application of active rTMS as well as before and after sham rTMS. We will compare the change in IEDs induced by the active and sham stimulation.

Time frame:
Before and after intervention (approximately 4 hours/visit on 2 study days one week apart)
Reported as:
Median · IEDs per 5 minutes
Interictal Epileptiform Discharge (IED) Frequency
IEDs per 5 minutesChildren With SeLECTS - Active rTMSChildren With SeLECTS - Sham rTMS
Before rTMS0 (0 to 20.5)0 (0 to 18)
After rTMS0 (0 to 12)0 (0 to 18.5)
Change from pre-rTMS to post-rTMS0 (-6.5 to 0)0 (-1 to 0)
Statistical analysis
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.04 (The a priori threshold for statistical significance was \<0.05.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.46 (The a priori threshold for statistical significance was \<0.05.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.12 (The a priori threshold for statistical significance was \<0.05.)
SecondaryChange in Brain Connectivity

We will measure brain connectivity before and after application of active rTMS as well as before and after sham rTMS. We will compare the change in connectivity induced by the active and sham stimulation. In particular, we will look at how connectivity changes between the motor cortex and language regions of the brain. We chose 3 regions of interest per hemisphere (-F: Frontal, -M: Motor, -T: Temporal). rTMS was applied to the hemisphere with more spikes on clinical EEG, and hence all regions were further qualified as being ipsilateral (i-) or contralateral (c-) to rTMS application. Connectivity is measured in the weighted Phase Lag Index (wPLI) in the beta-frequency band, a phase-based connectivity measure which runs from a theoretical minimum of 0 (no connectivity) to 1 (complete connectivity).

Time frame:
Before and after intervention (approximately 4 hours/visit on 2 study days one week apart)
Reported as:
Median · wPLI
Change in Brain Connectivity
wPLIChildren With SeLECTS - Active rTMSChildren With SeLECTS - Sham rTMS
Change in cF-iT Connectivity-0.025147033 (-0.06736053235 to -0.009095556347)0.001240549 (-0.01674470333 to 0.03546101011)
Change in cM-iT Connectivity-0.026464821 (-0.09033280758 to -0.004439810119)0.015413055 (-0.009845339466 to 0.05680533952)
Change in iF-cM Connectivity-0.038566551 (-0.07507071808 to -0.000831546384)0.009032342 (-0.01706492182 to 0.02160196731)
Change in iF-iT Connectivity-0.031871907 (-0.06020716415 to -0.008456458479)0.005724761 (-0.01917787091 to 0.03179566288)
Change in iF-cF Connectivity-0.017828074 (-0.131733617 to -0.005389702698)0.004773205 (-0.01693847284 to 0.04093271291)
Change in iM-cT Connectivity-0.016437136 (-0.05883184645 to 0.009583756)0.010533673 (-0.01520736144 to 0.02572202471)
Change in iF-cT Connectivity-0.017946561 (-0.05996626405 to 0.001548810394)0.008023921 (-0.005516234384 to 0.02195947435)
Change in iF-iM Connectivity-0.028419447 (-0.06790541051 to -0.01930392446)0.011937066 (-0.01998846337 to 0.03538472482)
Change in iT-cT Connectivity-0.041984947 (-0.08226344292 to 0.00820188987)-0.000655525 (-0.009649517287 to 0.0352091797)
Change in cF-cT Connectivity-0.022140561 (-0.04754855866 to 0.006893751688)0.006909577 (-0.01526276726 to 0.03540581226)
Change in cF-cM Connectivity-0.011221254 (-0.0543134682 to 0.006043824425)0.009773165 (-0.009669095958 to 0.03596951991)
Change in cF-iM Connectivity-0.031668097 (-0.05419498148 to 0.003974133567)0.01966644 (-0.009877540375 to 0.0318713625)
Change in iM-iT Connectivity-0.030898043 (-0.05097858412 to -0.003586219461)0.002850137 (-0.004130106912 to 0.02728766311)
Change in cM-cT Connectivity-0.029060306 (-0.05558707448 to 0.01102180261)-0.00727134 (-0.0244931598 to 0.02049569394)
Change in iM-cM Connectivity-0.032771045 (-0.07116425937 to 0.004104307197)0.004707047 (-0.02741234695 to 0.02510245297)
Statistical analysis
  • Children With SeLECTS - Active rTMS · Wilcoxon signed-rank test · p = <0.0001 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.69 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = <0.0001 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = <0.0001 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.43 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = <0.0001 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.002 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.54 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.007 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.002 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.32 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.01 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.003 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.29 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.02 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.003 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.66 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.008 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.005 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.87 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.11 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.012 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.46 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.02 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.01 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.99 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.04 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.01 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.31 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.05 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.03The threshold for statistical significance was p \< 0.0076.
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.20 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.04 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.05 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.59 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.12 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.10 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.57 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.06 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.12 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.69 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.14 (The threshold for statistical significance was p \< 0.0071.)
  • Children With SeLECTS - Active rTMS · Wilcoxon signed rank test · p = 0.12 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.60 (The threshold for statistical significance was p \< 0.0076.)
  • Children With SeLECTS - Active rTMS vs Children With SeLECTS - Sham rTMS · Wilcoxon signed rank test · p = 0.04 (The threshold for statistical significance was p \< 0.0071.)

Adverse events

Collected over 1 week. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Children With SeLECTS - Active rTMS0/19 (0%)0/19 (0%)2/19 (10.5%)
Children With SeLECTS - Sham rTMS0/19 (0%)0/19 (0%)0/19 (0%)
Most frequent other events
Most frequent other events
EventChildren With SeLECTS - Active rTMSChildren With SeLECTS - Sham rTMS
Head pain during stimulationNervous system disorders2/190/19

Baseline characteristics

Participants with Analyzable Data (Remained awake for both active \& sham rTMS sessions)

Age, Continuous
Age, Continuous(years)Children With SeLECTS - Active, Then Sham rTMSChildren With SeLECTS - Sham, Then Active rTMSTotal
Mean9.6 ± 1.410.1 ± 1.89.8 ± 1.6
Sex: Female, Male
Sex: Female, Male(Participants)Children With SeLECTS - Active, Then Sham rTMSChildren With SeLECTS - Sham, Then Active rTMSTotal
Female145
Male10414
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Children With SeLECTS - Active, Then Sham rTMSChildren With SeLECTS - Sham, Then Active rTMSTotal
Hispanic or Latino123
Not Hispanic or Latino10616
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Children With SeLECTS - Active, Then Sham rTMSChildren With SeLECTS - Sham, Then Active rTMSTotal
American Indian or Alaska Native000
Asian134
Native Hawaiian or Other Pacific Islander000
Black or African American000
White10414
More than one race011
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)Children With SeLECTS - Active, Then Sham rTMSChildren With SeLECTS - Sham, Then Active rTMSTotal
United States11819
08

Study locations

1 site
  • Stanford University School of Medicine
    Palo Alto, California 94304, United States
09

References and documents

Publications

  • Baumer FM, Pfeifer K, Fogarty A, Pena-Solorzano D, Rolle CE, Wallace JL, Rotenberg A, Fisher RS. Cortical Excitability, Synaptic Plasticity, and Cognition in Benign Epilepsy With Centrotemporal Spikes: A Pilot TMS-EMG-EEG Study. J Clin Neurophysiol. 2020 Mar;37(2):170-180. doi: 10.1097/WNP.0000000000000662. PubMed 32142025 ↗
  • Mishra A, Maiti R, Mishra BR, Jena M, Srinivasan A. Effect of Repetitive Transcranial Magnetic Stimulation on Seizure Frequency and Epileptiform Discharges in Drug-Resistant Epilepsy: A Meta-Analysis. J Clin Neurol. 2020 Jan;16(1):9-18. doi: 10.3988/jcn.2020.16.1.9. PubMed 31942753 ↗
  • Chen R, Spencer DC, Weston J, Nolan SJ. Transcranial magnetic stimulation for the treatment of epilepsy. Cochrane Database Syst Rev. 2016 Aug 11;(8):CD011025. doi: 10.1002/14651858.CD011025.pub2. PubMed 27513825 ↗
  • She X, Qi W, Nix KC, Menchaca M, Cline CC, Wu W, He Z, Baumer FM. Repetitive transcranial magnetic stimulation modulates brain connectivity in children with self-limited epilepsy with centrotemporal spikes. Brain Stimul. 2025 Mar-Apr;18(2):287-297. doi: 10.1016/j.brs.2025.02.018. Epub 2025 Feb 24. PubMed 40010636 ↗
  • She X, Nix KC, Cline CC, Qi W, Tugin S, He Z, Baumer FM. Stability of transcranial magnetic stimulation electroencephalogram evoked potentials in pediatric epilepsy. Sci Rep. 2024 Apr 20;14(1):9045. doi: 10.1038/s41598-024-59468-8. PubMed 38641629 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — No current plan.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2020 to primary completion in Mar 2024, 40 months.

Results were first posted in Sep 2025, 1 year 6 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2020
First posted
Mar 27, 2020
StartActual
Oct 28, 2020
Primary completionActual
Mar 3, 2024
CompletionActual
Mar 3, 2024
Results first posted
Sep 4, 2025
Last update
Sep 4, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04325282
Responsible party
Fiona Baumer (Instructor, Stanford University) — Principal investigator
First posted
Mar 27, 2020
Start date
Oct 28, 2020
Primary completion
Mar 3, 2024
Completion
Mar 3, 2024
Results posted
Sep 4, 2025
Last update
Sep 4, 2025

Study contacts

Fiona M Baumer, MD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion